AbbVie (ABBV) Issues Q2 and FY25 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| AbbVie (NYSE: ABBV) | Delayed: 265.76 +2.94 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.82 | 52 Week High | $68.12 | |||
| Open | $261.27 | 52 Week Low | $50.71 | |||
| Day High | $267.34 | P/E | 57.65 | |||
| Day Low | $260.29 | EPS | $4.61 | |||
| Volume | 7,544,173 | |||||
